☆ 4.8 Article

A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Oncology

Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers

Guoying Zhou et al.

Summary: Liver cancer, particularly hepatocellular carcinoma and cholangiocarcinoma, presents challenges in immune-mediated tumour control due to the immunosuppressive tumour microenvironment. Although key co-inhibitory immune checkpoint interactions play a critical role, only a minority of patients respond to monotherapy using approved checkpoint inhibitor antibodies. Further research is needed to identify alternative immune checkpoints and explore combined targeting of co-inhibitory and co-stimulatory pathways to overcome immunosuppression.

BRITISH JOURNAL OF CANCER (2022)

Add to Collection

Review Oncology

Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma

David A. Braun et al.

Summary: The management of advanced-stage renal cell carcinoma has been transformed by the development of immune-checkpoint inhibitors (ICIs). However, most patients do not derive durable clinical benefit from these agents. Innovations in immunotherapy for RCC, including ICIs with novel targets, are now in clinical development.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection

Article Cell Biology

Construction and characterization of rectal cancer-related lncRNA-mRNA ceRNA network reveals prognostic biomarkers in rectal cancer

Guoying Cai et al.

Summary: Rectal cancer is a significant cause of cancer-related deaths globally. This study identified highly correlated lncRNA-mRNA pairs with strong prognostic effects, constructed a network based on the ceRNA theory, and uncovered key regulators in tumourigenesis through topological analysis and hub subnetwork construction. The findings provide promising clues for biological prognosis of rectal cancer.

IET SYSTEMS BIOLOGY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma

David F. McDermott et al.

Summary: Single-agent pembrolizumab demonstrated promising antitumor activity as a first-line treatment in untreated patients with advanced ccRCC, with durable responses observed across different categories. The safety and tolerability profile of pembrolizumab monotherapy was consistent with what has been observed in other tumor types.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

Alexander Chehrazi-Raffle et al.

Summary: This study found that specific plasma cytokines were associated with clinical benefit in patients with renal cell carcinoma receiving VEGF-TKI or ICI therapy. These findings support further investigation into plasma cytokines as potential biomarkers for renal cell carcinoma.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Immunology

Six distinct NFκB signaling codons convey discrete information to distinguish stimuli and enable appropriate macrophage responses

Adewunmi Adelaja et al.

Summary: The dynamics of NF kappa B signaling can classify immune threats through six signaling codons, and confusion of these codons may underlie the etiology of some inflammatory diseases.NF kappa B activity determines the type of gene expression and response in macrophages. An oscillatory trajectory is a hallmark of responses to cytokine stimuli.

IMMUNITY (2021)

Add to Collection

Review Cell Biology

From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma

Jonathan Anker et al.

Summary: Immunotherapy has revolutionized the treatment of many cancer types, with particular progress seen in the treatment of renal cell carcinoma. While clinical benefit from immunotherapy is limited to certain patients, combination-based approaches have shown improved outcomes. Ongoing translational work has helped illuminate response mechanisms and resistance to immunotherapy, shaping the future of treatment for RCC.

CELLS (2021)

Add to Collection

Article Oncology

METTL1 promotes hepatocarcinogenesis via m7G tRNA modification-dependent translation control

Zhihang Chen et al.

Summary: The N-7-methylguanosine (m(7)G) modification is a common transfer RNA (tRNA) modification in humans. Elevated levels of METTL1 and WDR4 in hepatocellular carcinoma (HCC) are associated with advanced tumor stages and poor patient survival. Mechanistically, METTL1-mediated tRNA m(7)G modification promotes the translation of target mRNAs with higher frequencies of m(7)G-related codons, providing new insights into the role of misregulated tRNA modifications in liver cancer.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Evolution of Methyltransferase-Like (METTL) Proteins in Metazoa: A Complex Gene Family Involved in Epitranscriptomic Regulation ana Other Epigenetic Processes

Juliet M. Wong et al.

Summary: The study investigates the evolutionary mechanisms of 33 individual METTL proteins in animals, revealing that they are widely distributed in the animal kingdom and mostly originated early in metazoan evolution. Each METTL lineage originated from a single independent ancestor, forming monophyletic clades, indicating strong selective constraints driving their specialization. However, nucleoside-modifying and protein-modifying METTLs did not form unique monophyletic clades, and showed differences in their rates of evolution.

MOLECULAR BIOLOGY AND EVOLUTION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

Balazs Gyorffy

Summary: This study presents a ranking of all survival-related genes in chemotherapy treated basal and estrogen positive/HER2 negative breast cancer, providing a reference for future biomarker research. By analyzing hazard rates and p values of genes, the most promising prognostic genes can be identified, helping to focus research on candidates with the most clinical significance.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Add to Collection

Review Urology & Nephrology

Checkpoint inhibitor immunotherapy in kidney cancer

Wenxin Xu et al.

NATURE REVIEWS UROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

TIMER2.0 for analysis of tumor-infiltrating immune cells

Taiwen Li et al.

NUCLEIC ACIDS RESEARCH (2020)

Add to Collection

Article Oncology

The Mincle/Syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages

Chunjie Li et al.

CANCER IMMUNOLOGY RESEARCH (2020)

Add to Collection

Article Oncology

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors

Jayesh Desai et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Add to Collection

Article Biochemistry & Molecular Biology

METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer

Xiaoxiang Chen et al.

MOLECULAR CANCER (2020)

Add to Collection

Review Urology & Nephrology

The immunology of renal cell carcinoma

C. Marcela Diaz-Montero et al.

NATURE REVIEWS NEPHROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Upregulation of METTL14 mediates the elevation ofPERPmRNA N6adenosine methylation promoting the growth and metastasis of pancreatic cancer

Min Wang et al.

MOLECULAR CANCER (2020)

Add to Collection

Article Genetics & Heredity

hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets

Qiong Zhang et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2020)

Add to Collection

Review Oncology

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Daniela Bruni et al.

NATURE REVIEWS CANCER (2020)

Add to Collection

Article Oncology

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry

M. Fishman et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity

Mikhail Binnewies et al.

CELL (2019)

Add to Collection

Article Biochemistry & Molecular Biology

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma

Ting Li et al.

MOLECULAR CANCER (2019)

Add to Collection

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Suhas V. Vasaikar et al.

NUCLEIC ACIDS RESEARCH (2018)

Add to Collection

Article Pathology

Trends in reporting histological subtyping of renal cell carcinoma: association with cancer center type

Ted Gansler et al.

HUMAN PATHOLOGY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Add to Collection

Article Cell Biology

Immunometabolism in cancer at a glance

Katrin Singer et al.

DISEASE MODELS & MECHANISMS (2018)

Add to Collection

Editorial Material Immunology

Kidney cancer: The next decade

Samra Turajlic et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Add to Collection

Review Oncology

Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy

A. Rotte et al.

ANNALS OF ONCOLOGY (2018)

Add to Collection

Review Cell Biology

Regulatory T cells in cancer immunotherapy

Atsushi Tanaka et al.

CELL RESEARCH (2017)

Add to Collection

Article Oncology

The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma

Xiao Li et al.

ONCOTARGET (2017)

Add to Collection

Article Oncology

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

Darshan S. Chandrashekar et al.

NEOPLASIA (2017)

Add to Collection

Review Oncology

Treatment of renal cell carcinoma: Current status and future directions

Pedro C. Barata et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Add to Collection

Article Medicine, General & Internal

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Bernard Escudier et al.

LANCET (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.